OCULOPHARYNGEAL MUSCULAR DYSTROPHY
Clinical trials for OCULOPHARYNGEAL MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new OCULOPHARYNGEAL MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for OCULOPHARYNGEAL MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy injection aims to restore swallowing in rare muscle disease
Disease control Recruiting nowThis study tests a single injection of BB-301 into throat muscles to improve swallowing in people with oculopharyngeal muscular dystrophy (OPMD). About 30 adults aged 50-65 with swallowing difficulties will receive the treatment during a short surgery. The main goals are to check…
Matched conditions: OCULOPHARYNGEAL MUSCULAR DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: Benitec Biopharma, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Spit test may reveal clues to rare muscle disease
Knowledge-focused Recruiting nowThis study looks at saliva from people with Oculopharyngeal Muscular Dystrophy (OPMD) and their household members. Researchers want to see if swallowing problems affect oral health and if saliva thickness or certain chemicals can help detect the disease. About 100 participants wi…
Matched conditions: OCULOPHARYNGEAL MUSCULAR DYSTROPHY
Sponsor: Sheba Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 10:57 UTC